Status:
COMPLETED
Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
Lead Sponsor:
Pfizer
Conditions:
Essential Hypertension
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Efficacy, tolerability and safety of olmesartan alone or in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension
Eligibility Criteria
Inclusion
- Subject has mild to moderate hypertension
Exclusion
- History of secondary hypertension
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
410 Patients enrolled
Trial Details
Trial ID
NCT00139698
Start Date
September 1 2005
End Date
July 1 2006
Last Update
December 5 2018
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Medellín, Antioquia, Colombia
2
Pfizer Investigational Site
Barranquilla, Atlántico, Colombia
3
Pfizer Investigational Site
Cartagena, Atlántico, Colombia
4
Pfizer Investigational Site
Bogota, Cundinamarca, Colombia